From: Polymorphisms in the glutathione pathway modulate cystic fibrosis severity: a cross-sectional study
Pancreatic status | Groups | N | Mean (months) | Standard deviation | Confidential interval | Minimum (months) | Maximum (months) | p-value | Osteoporosis (N/%) | p-value | |
---|---|---|---|---|---|---|---|---|---|---|---|
5% | 95% | ||||||||||
No mutation identified | 44 | 211.75 | 217.501 | 145.62 | 277.88 | 25 | 932 | 8 (19%) | |||
Pancreatic insufficiency + Pancreatic sufficiency | One CFTR mutation identified | 51 | 201.18 | 165.050 | 154.76 | 247.60 | 11 | 782 | 0.854 | 9 (17.6%) | |
Two mutation identified | 84 | 220.06 | 188.643 | 179.12 | 261.00 | 7 | 1274 | 12 (14.3%) | 0.761 | ||
Pancreatic insufficiency | One CFTR mutation identified | 35 | 221.57 | 216.17 | 147.31 | 295.83 | 25 | 932 | 7 (21.2%) | ||
Two mutation identified | 43 | 198.81 | 171.31 | 146.09 | 251.54 | 11 | 782 | 0.940 | 5 (11.6%) | 0.345 |